Cost-effectiveness of respiratory syncytial virus prophylaxis with palivizumab.

Archives of pediatrics & adolescent medicine

PubMedID: 17485634

Mahadevia PJ, Malinoski FJ. Cost-effectiveness of respiratory syncytial virus prophylaxis with palivizumab. Arch Pediatr Adolesc Med. 2007;161(5):519-20; author reply 520.
An abstract is not available. Please access the article through the links below.